Taia T. Wang

TL;DR: It is proposed that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19.

TL;DR: The construction of a novel immunogen comprising the conserved influenza HA stalk domain and lacking the globular head is described, which shows that vaccination of mice with a headless HA confers protection to these animals against a lethal influenza virus challenge, and predicts that a single immunization with aHeadless HA vaccine will offer effective protection through several influenza epidemics.

TL;DR: The diverse downstream proinflammatory, anti-inflammatory and immunomodulatory consequences of the engagement of type I and type II Fc receptors in the context of infectious, autoimmune, and neoplastic disorders are discussed.

TL;DR: Outpatient and asymptomatic individuals’ SARS-CoV-2 antibodies, including IgG, progressively decreased during observation up to five months post-infection, but antibody responses in acute illness were insufficient to predict inpatient outcomes.

TL;DR: A hemagglutinin subunit 2 protein (HA2)-based synthetic peptide vaccine that provides protection in mice against influenza viruses of the structurally divergent subtypes H3N2, H1N1, and H5N1 is described.